Thyroid function in pregnant women with thyroid peroxidase antibodies

Authors

DOI:

https://doi.org/10.15574/PP.2023.96.37

Keywords:

pregnancy, thyroid function, antibodies to thyroid peroxidase, thyroid-stimulating hormone, thyroxine, triiodothyronine, ioduria

Abstract

Purpose - to study the function of the thyroid gland (TG) in pregnant women with antibodies to thyroid peroxidase (AB-TPO) during pregnancy.

Materials and methods. The clinical group included 158 patients. The Group I - 69 pregnant women with a level of AB-TPO<350 IU/ml, the Group II - 59 pregnant women with a level of AB-TPO>350 IU/ml, the Control group - 30 conditionally healthy women without an elevated level of AB-TPO and with a physiological course of pregnancy. To determine the volume of TG the J. Brunn formula was used during ultrasound examination. Statistical processing of research results was carried out using standard Microsoft Excel 5.0 and Statistica 6.0 programs.

Results. It was established that the level of thyroid-stimulating hormone (TSH) in the I trimester has a physiologically low value - 1.2 (0.9; 1.4) mIU/l; during pregnancy its level increased to 1.6 (1.3; 1.8) mIU/l; p<0.001. The median indicator of free thyroxine (FT4) at 7-8 weeks was at the level of 18.2 (16.2; 20.7) pmol/l; by the II trimester, it increased by 12.00% from the baseline, was 20.1 (16.2; 22.8) pmol/l; p<0.001; by the end of pregnancy - 19.6 (17.6; 20.1) pmol/l; p=0.17. The median indicator of free triiodothyronine (FT3) in the II trimester was higher by 13.6% than in the early stages of pregnancy, p=0.01. It was established that 27.5% of patients of the Group I and 30.5% of pregnant women of the Group II had laboratory signs of subclinical hypothyroidism (TSH>3.5 mIU/l) before the III trimester; p<0.05. A decrease in the production of FT3 and FT4 reflects the exhaustion of the compensatory capabilities of TG in pregnant women carriers of AB-TPO at a concentration above 350 IU/ml. Before the end of pregnancy, 17.4% of patients of the Group I and 20.3% of pregnant women of the Group II were diagnosed with manifest hypothyroidism.

Conclusions. In pregnant women with a normal level of AB-TPO in the early stages of pregnancy, a physiological decrease in the level of TSH with subsequent normalization in the II and III trimesters is determined; FT4 and FT3 levels increase with increasing gestational age; the volume of TG physiologically increased by 15.2% from the indicators of the early periods, which requires regular monitoring of the thyroid status in the dynamics of pregnancy and timely correction.

Тhe research was conducted according to principles of Declaration of Helsinki. Protocol of research was proved by local ethical committee, mentioned in institution’s work. A informed sonsennt was collected in order to carry out the research.

No conflict of interests was declared by the authors.

References

Ahtamovna ZZ. (2022). Secondary infertility in women of reproductive age with hypothyroidism. ACADEMICIA: An International Multidisciplinary Research Journal. 12 (5): 649-653. https://doi.org/10.5958/2249-7137.2022.00424.4

Ajmani NS, Sarbhai V, Yadav N, Paul M, Ahmad A, Ajmani AK. (2016, Apr). Role of Thyroid Dysfunction in Patients with Menstrual Disorders in Tertiary Care Center of Walled City of Delhi. J Obstet Gynaecol India. 66 (2): 115-119. Epub 2015 Jan 20. https://doi.org/10.1007/s13224-014-0650-0; PMid:27046965 PMCid:PMC4818825

Akande AA, Isah IA, Aliyu IS, Adesiyun AG. (2022, Jun). Thyroid dysfunction in women of reproductive age: laboratory protocol for infertility evaluation. Ann Ib Postgrad Med. 20 (1): 53-57. PMID: 37006645; PMCID: PMC10061663.

Aleksieieva OS, Lazurenko VV, Liashchenko OA, Safonov RA, Striukov DV, Afanasiev IV. (2021). Anomalni matkovi krovotechi u zhinok iz patolohiieiu shchytopodibnoi zalozy (ohliad literatury). Mizhnarodnyi medychnyi zhurnal. 27 (2): 57-64.

Aljarad M, Alhalabi N, Hamad A, Nmr N, Abbas F, Alkhatib A, Alhalabi M, Al-Hammami H, Ibrahim N. (2019, Aug 3). Prevalence of Thyroid Autoimmune Antibodies in Women Seeking Fertility Care in Damascus, Syria. Cureus. 11 (8): e5315. https://doi.org/10.7759/cureus.5315; PMid:31592370 PMCid:PMC6773447

Brunn J, Block U, Ruf G, Bos I, Kunze WP, Scriba PC. (1981). Volumetric analysis of thyroid lobes by real-time ultrasound. Dtsch Med Wochenschr. 106 (41): 1338-1340. https://doi.org/10.1055/s-2008-1070506; PMid:7274082

Chaudhary A, Bhatia BK. (2021). Relationship between thyroid disorder and abnormal menstrual bleeding. Int. J. Cur. Res. Rev. 13 (2): 29-32. https://doi.org/10.31782/IJCRR.2021.13216

Fan J, Zhang Y, Zhang C, Barjaktarovic M, Yang X, Peeters RP, Korevaar TI. (2019). Persistency of thyroid dysfunction from early to late pregnancy. Thyroid. 29 (10): 1475-1484. https://doi.org/10.1089/thy.2019.0115; PMid:31347461

Jenishia M. (2020). Thyroid Disorders during Pregnancy. International Journal of Nursing Education and Research. 8.3: 391-393. https://doi.org/10.5958/2454-2660.2020.00084.8

Kahaly GJ, Bartalena L, Hegedüs L, Leenhardt L, Poppe K, Pearce SH. (2018). European Thyroid Association Guideline for the Management of Graves' Hyperthyroidism. Eur Thyroid J. 7 (4): 167-186. Epub 2018 Jul 25. https://doi.org/10.1159/000490384; PMid:30283735 PMCid:PMC6140607

Kahaly GJ. (2020, Dec 1). Management of Graves Thyroidal and Extrathyroidal Disease: An Update. J Clin Endocrinol Metab. 105 (12): 3704-3720. https://doi.org/10.1210/clinem/dgaa646; PMid:32929476 PMCid:PMC7543578

Khabrat BV, Khabrat AB, Lytvak OO, Lysenko BM. (2018). Analiz kliniko-anamnestychnykh chynnykiv rozvytku henitalnoho endometriozu na tli tyreoïdnoï dysfunktsiï. Ukr. zhurn. medytsyny, biolohiï ta sportu. 3 (6): 167-179. https://doi.org/10.26693/jmbs03.06.167

Kiran Z, Sheikh A, Malik S, Meraj A, Masood M, Ismail S, Islam N. (2019). Maternal characteristics and outcomes affected by hypothyroidism during pregnancy (maternal hypothyroidism on pregnancy outcomes, MHPO-1). BMC pregnancy and childbirth. 19 (1): 1-12. https://doi.org/10.1186/s12884-019-2596-9; PMid:31805890 PMCid:PMC6896307

Knøsgaard L et al. (2020). Thyroid function abnormalities and thyroid autoantibodies in Danish pregnant women. Clinical Endocrinology. 93.3: 329-338. https://doi.org/10.1111/cen.14147; PMid:31876038

Kundoor R, Rani BS. (2019). Thyroid function in abnormal uterine bleeding. Int. J. Reprod. Contracept. Obstet. and Gynecol. 8 (6): 2270-2274. https://doi.org/10.18203/2320-1770.ijrcog20192416

Lee MK, Na DG, Joo L, Lee JY, Ha EJ, Kim JH, Jung SL, Baek JH. (2023, Jan). Standardized Imaging and Reporting for Thyroid Ultrasound: Korean Society of Thyroid Radiology Consensus Statement and Recommendation. Korean J Radiol. 24 (1): 22-30. https://doi.org/10.3348/kjr.2022.0894; PMid:36606617 PMCid:PMC9830140

Lee SY, Pearce EN. (2021). Testing, monitoring, and treatment of thyroid dysfunction in pregnancy. The Journal of Clinical Endocrinology & Metabolism. 106 (3): 883-892. https://doi.org/10.1210/clinem/dgaa945; PMid:33349844 PMCid:PMC7947825

Li N, Yang J, Chen X, Huang J, Lai M, Fang F, Peng YD. (2020). Postpartum follow-up of patients with subclinical hypothyroidism during pregnancy. Thyroid. 30 (11): 1566-1573. https://doi.org/10.1089/thy.2019.0714; PMid:32375594

Mintser AP. (2010). Statisticheskie metodyi issledovaniya v klinicheskoy meditsine. Prakticheskaya meditsina. 3: 41-45.

Romanenko TH, Chay̆ka OI. (2017). Osoblyvosti menstrualnoï funktsiï u zhinok z bezplidnistiu na tli patolohiï shchytopodibnoï zalozy. Zdorove zhenshchyni. 6: 40-44. doi: https://doi.org/10.15574/ hw.2017.122.40.

Semeniuk LM, Lytvak OO, Naustynna LS, Hyriavenko OIa. (2016). Strukturno-metabolichni osoblyvosti budovy endometriia u zhinok piznoho reproduktyvnoho viku z dobroiakisnymy tyreopatiiamy. M. Ye. Yarotskyy̆ ta in. Endokrynolohiia. 21 (1): 51-56. https://doi.org/10.9790/0837-2110025156

Silva JF, Ocarino NM, Serakides R. (2018). Thyroid hormones and female reproduction. Biol. Reprod. 99 (5): 907-921. https://doi.org/10.1093/biolre/ioy115; PMid:29767691

Van Trotsenburg ASP. (2020, Jul). Management of neonates born to mothers with thyroid dysfunction, and points for attention during pregnancy. Best Pract Res Clin Endocrinol Metab. 34 (4): 101437. Epub 2020 Jun 18. https://doi.org/10.1016/j.beem.2020.101437; PMid:32651060

Verma A, Kaur AP, Shergill HK, Kaur S. (2017). Menstrual disorders in thyroid dysfunction. Eur. J. of Bio- medical. 4 (2): 197-201.

Wang J, Gong XH, Peng T, Wu JN. (2021). Association of thyroid function during pregnancy with the risk of pre-eclampsia and gestational diabetes mellitus. Endocrine Practice. 27 (8): 819-825. https://doi.org/10.1016/j.eprac.2021.03.014; PMid:33831553

Wang Y, Zhou R, Wang J. (2019). Relationship between hypothyroidism and endometrial cancer. Aging Dis. 10 (1): 190-196. https://doi.org/10.14336/AD.2018.0224; PMid:30705778 PMCid:PMC6345335

Xie J et al. (2020). Effect of antithyroid antibodies on women with recurrent miscarriage: A meta-analysis. Am. J. Reprod. Immunol. 83 (6): e13238. https://doi.org/10.1111/aji.13238; PMid:32198952 PMCid:PMC7317526

Yuzko OM. (2018). Porushennia funktsiï shchytopodibnoï zalozy v zhinok iz bezpliddiam ta anomalnymy matkovymy krovotechamy. Klinichna ta eksperymentalna medytsyna. 17 (3, 65): 109-112. doi: 10.24061/1727-4338.XVII.3.65.2018.142.

Zhang Y, Li Y, Shan Z, Xu Y, Li C, Xie X, Teng W. (2019). Association of overt and subclinical hyperthyroidism during weeks 4-8 with adverse pregnancy outcomes. Journal of Women's Health. 28 (6): 842-848. https://doi.org/10.1089/jwh.2018.7180; PMid:30855205

Published

2023-12-28